TY - JOUR
T1 - First successful transapical aortic valve implantation with the corevalve Revalving™ system
T2 - A case report
AU - Lange, Rüdiger
AU - Schreiber, Christian
AU - Götz, Wolfgang
AU - Hettich, Ina
AU - Will, Albrecht
AU - Libera, Paul
AU - Laborde, Jean Claude
AU - Bauernschmitt, Robert
PY - 2007
Y1 - 2007
N2 - On June 26, 2007, the Clinic for Cardiovascular Surgery at the German Heart Center Technical University in Munich successfully implanted a bioprosthetic valve via the apex of the heart within the framework of the CoreValve TAVR ReValving (CoreValve Inc., Irvine, CA, USA) clinical trial. The self-expanding aortic valve prosthesis is primarily designed for retrograde delivery across the aortic valve. The described transapical approach, however, now allows for treatment in those patients who have, for instance, no adequate "access" in the groin vessels due to peripheral vascular disease. Therefore, its feasibility must be considered as a major step in treating high-risk patients.
AB - On June 26, 2007, the Clinic for Cardiovascular Surgery at the German Heart Center Technical University in Munich successfully implanted a bioprosthetic valve via the apex of the heart within the framework of the CoreValve TAVR ReValving (CoreValve Inc., Irvine, CA, USA) clinical trial. The self-expanding aortic valve prosthesis is primarily designed for retrograde delivery across the aortic valve. The described transapical approach, however, now allows for treatment in those patients who have, for instance, no adequate "access" in the groin vessels due to peripheral vascular disease. Therefore, its feasibility must be considered as a major step in treating high-risk patients.
UR - http://www.scopus.com/inward/record.url?scp=37549043840&partnerID=8YFLogxK
U2 - 10.1532/HSF98.20071140
DO - 10.1532/HSF98.20071140
M3 - Article
C2 - 18187382
AN - SCOPUS:37549043840
SN - 1098-3511
VL - 10
SP - 333
EP - 334
JO - The heart surgery forum
JF - The heart surgery forum
IS - 6
ER -